PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Conditions:   Solid Tumor, Adult;   Breast Cancer;   Non Small Cell Lung Cancer;   Prostate Cancer;   Ovarian Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Cholangiocarcinoma
Intervention:   Drug: CX-2009
Sponsor:   CytomX Therapeutics
Not yet recruiting - verified May 2017

http://ift.tt/2pBud9q